and an important factor in fatty acid metabolism in skeletal muscle, heart, and liver
Use of the medications to support weight loss was higher among women than men (4% vs 1.7%) and higher among those of middle age (4.2% of 45- and 55-year-olds compared to 1.2% of 18-year-olds and 1.5% of 75-year-olds***)
Cohort 2 consisted of patients (not in cohort 1) who received 6 or more intramuscular injections within 1 year and had a laboratory test 2 months before the intramuscular injection claim
None of it establishes a benefit, effect or outcome in humans, and Kovalabs makes no such claim
Before initiating therapy, patient selection must be rigorous, and baseline indicatorssuch as estimated glomerular filtration rate (eGFR), serum potassium (K + ) levels, blood pressure, and volume statusmust be comprehensively assessed